ARCHIVES

Nexavar Improves PFS In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

NCI Role, Issues In Education Considered By DRCCA Board

August 21, 1981

Health Canada Suspends Avastin Approval; CMS Has Taken No Action After FDA Decision

December 2, 2011

In Brief: Brandt Names To Health Position; Everett Koop Would Be Surgeon General In HHS Reorganization

February 20, 1981

Amgen Pays $24.9 Million To Settle Kickback Charges

April 19, 2013

The Cancer Letter Stands By Story

October 30, 1998

Hammer Goes Public With Appeal for Increased Funding

March 14, 1986